Table 1 Demographic characteristics of PWID living with HCV
Characteristic | Overall (n = 40) |
|---|---|
Age (Median, IQR) | 37 (32–45) |
Gender | |
 Male | 26 (65%) |
 Female | 13 (33%) |
 Non-binary (assigned male at birth) | 1 (3%) |
Race | |
 American Indian/Alaska native | 7 (18%) |
 Asian | 1 (3%) |
 African-American/Black | 1 (3%) |
 White | 21 (53%) |
Multiple Races | 5 (13%) |
 Other race(s) | 5 (13%) |
 Hispanic ethnicity | 7 (18%) |
Housing status | |
 Stably housed | 8 (20%) |
 Not stably housed | 32 (80%) |
Drug(s) used at last injection episode | |
Single drugs | Â |
 Heroin, alone | 14 (35%) |
 Methamphetamine, alone | 4 (10%) |
Combinations of drugs | |
 Heroin and methamphetamine | 15 (38%) |
 Heroin, methamphetamine, and fentanyl | 4 (10%) |
 Heroin, methamphetamine, and cocaine | 1 (2%) |
 Heroin, methamphetamine, and methadone | 1 (2%) |
 Heroin, methamphetamine, cocaine, and fentanyl | 1 (2%) |
Days injected in past month (Median, IQR) | 30 (25–30) |
Injecting episodes on an average day (Median, IQR) | 4 (3–4) |
Years injecting drugs (Median, IQR) | 11.5 (5–18) |
Years aware of HCV diagnosis (Median, IQR) | 2 (0.5–7) |
Level of concern about HIV acquisition among participants | Â |
 Extremely concerned | 12 (30%) |
 Very concerned | 4 (10%) |
 Moderately concerned | 3 (8%) |
 A little concerned | 8 (20%) |
 Not at all concerned | 9 (22%) |
 Refused | 1 (2%) |
 Missing | 3 (8%) |